Name: AXIM Income Statement - Axim Biotechnologies Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

AXIM - Axim Biotechnologies, Inc.

USD | OTC Markets | Healthcare

AXIM Income Statement - Axim Biotechnologies Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16	Q1 FY 16	Q4 FY 15	Q3 FY 15	Q2 FY 15	Q1 FY 15	Q4 FY 14	Q3 FY 14
Revenues
Revenues	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011
Revenues
Revenues	0.1	0.0	0.0	0.1	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cost of Revenue	-	-	-	-	0.0	0.0	0.0	0.0	0.2	0.1	0.0	-	-	-
Gross Profit	-	-	-	-	0.0	0.8	0.2	0.0	(0.1)	(0.0)	0.0	-	-	-
Operating Expenses
Research & Development	0.1	0.1	0.2	0.3	0.4	0.0	2.1	1.4	0.2	0.6	0.0	-	-	-
Operating Income
Operating Income	(2.3)	(2.8)	(4.7)	(14.0)	(4.9)	(3.1)	(5.0)	(3.1)	(3.8)	(10.0)	(0.5)	-	-	-
Non-Operating
Interest Income	-	0.0	0.0	0.0	0.0	-	0.0	0.0	0.0	-	-	-	-	-
Interest Expense
Tax & Net
Income Tax Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-
Net Income From Continuing Ops
Per Share
EPS Basic	-	(0.04)	(0.04)	0.12	(0.06)	(0.10)	-	-	-	-	-	-	-	-
EPS Diluted
Supplementary Data
EBITDA	(1.9)	(2.3)	(4.2)	(11.9)	(4.9)	(3.1)	(5.0)	(3.1)	(3.8)	(10.0)	(0.5)	-	-	-
EBIT

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Income
Operating Income	(0.6)	(0.4)	(0.8)	(0.6)	(0.7)	(0.7)	(1.1)	(1.3)	(1.1)	(1.1)	(7.6)	(3.3)	(2.2)	(0.9)	(2.3)	(1.3)	(0.7)	(0.7)	0.3	(0.5)	(0.6)	(2.3)	(0.7)	(0.9)	(1.3)	(2.0)	(1.1)	(1.2)	(0.4)	(0.5)	(0.8)	(1.6)	(0.5)	(0.9)	(6.3)	(1.7)	(1.6)	(0.5)	-	(0.1)

Per Share
EPS Basic	(0.01)	(0.00)	-	0.00	(0.02)	(0.01)	-	(0.01)	(0.01)	(0.01)	-	(0.03)	(0.03)	(0.01)	-	(0.02)	0.00	(0.03)	-	(0.01)	(0.03)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00
EPS Diluted	(0.01)	(0.00)	-	0.00	(0.02)	(0.01)	-	(0.01)	(0.01)	(0.01)	-	(0.03)	(0.03)	(0.01)	-	(0.02)	0.00	(0.03)
Shares Basic	-	-	-	232.4	226.3	-	-	171.9	154.9	-	-	-	-	-	-	-	-	-
Shares Diluted	-	-	-	478.5	226.3	-	-	-	154.9	-	-	-	-	-	-	-	-	-

Supplementary Data
EBITDA	(0.5)	(0.3)	(0.6)	(0.5)	(0.6)	(0.6)	(1.0)	(1.2)	(1.0)	(1.0)	(5.6)	(3.3)	(2.2)	(0.9)	-	(1.3)	-	(0.7)	-	-	-	(2.3)	-	-	-	(2.0)	-	-	-	(0.5)	(0.8)	(1.6)	(0.5)	(0.9)	(6.3)	(1.7)	(1.6)	(0.5)	-	-
EBIT	(0.6)	(0.4)	(0.8)	(0.6)	(0.7)	(0.7)	(1.1)	(1.3)	(1.1)	(1.1)	(7.6)	(3.3)	(2.2)	(0.9)	(2.3)	(1.3)	(0.7)	(0.7)	0.3